Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.780
+0.040 (2.30%)
At close: Sep 14, 2026, 4:00 PM EDT
1.790
+0.010 (0.56%)
After-hours: Sep 14, 2026, 7:45 PM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $129.02 million as of September 14, 2026. Its market cap has increased by 12.34% in one year.
Market Cap
129.02M
Enterprise Value
95.07M
1-Year Change
12.34%
Ranking
Category
Stock Price
$1.78
ChartMarket Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $129.02M, a decrease of -73.62%. That is a compound annual growth rate of -21.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 129.02M | 47.16% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Equillium | 133.79M |
| TuHURA Biosciences | 130.64M |
| Nautilus Biotechnology | 129.80M |
| Inovio Pharmaceuticals | 129.25M |
| Connect Biopharma Holdings | 128.47M |
| OnKure Therapeutics | 125.54M |
| Tiziana Life Sciences | 124.14M |
| ProMIS Neurosciences | 121.60M |